Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 60Head & Neck 47Gastrointestinal 30Genitourinary 16Gynecologic 11CNS 6Other solid neoplasm 5Lymphoid 4Endocrine 4Plasma cell 3Dermatologic 3Tumor-Agnostic 2Sarcoma 2Breast 2NET 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Melanoma 2Carcinoma, Non-Small-Cell Lung 2Colorectal Neoplasms 1Advanced Melanoma 1

Interventions

pembrolizumab 24Specimen Handling 21Nivolumab 20Magnetic Resonance Spectroscopy 16Ipilimumab 12Biopsy 9Cyclophosphamide 5CTLA-4 Antigen 5relatlimab 4Opdualag 4HhAntag691 4trametinib 3fludarabine 3dabrafenib 3cemiplimab 3binimetinib 3avelumab 3aldesleukin 3Surgical Procedures, Operative 3Radiosurgery 3Paclitaxel 3Cisplatin 3Carboplatin 3talimogene laherparepvec 2omipalisib 2capivasertib 2atezolizumab 2X-Rays 2Taxes 2Surveys and Questionnaires 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Cisplatin × Dermatologic × 30 days × Clear all
NCT03645928 2026-05-15

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

Iovance Biotherapeutics, Inc.

Phase 2 Terminated
225 enrolled
DermatologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma

NCT07310784 2026-05-12

A Phase II Trial of LM103 in Advanced Melanoma

Suzhou BlueHorse Therapeutics Co., Ltd.

Phase 2 Recruiting
92 enrolled
Dermatologic

Advanced Melanoma

NCT04083599 2026-05-06

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

Genmab

Phase 1/2 Active not recruiting
350 enrolled
DermatologicGastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡